| All patients (n = 45) | Mild (n = 15) | Moderate (n = 18) | Severe (n = 12) | p values |
Age, median (IQR), years | 64 (53 - 73) | 63 (54 - 72) | 65 (47 - 75) | 66 (52 - 73) | 0.929 |
≤65 | 23 (51.1%) | 9 (60.0%) | 9 (50.0%) | 5 (41.7%) | 0.644 |
>65 | 22 (48.9%) | 6 (40.0%) | 9 (50.0%) | 7 (58.3%) | |
Sex |
|
|
|
|
|
Female | 16 (35.6%) | 8 (53.3%) | 7 (38.9%) | 1 (8.3%) | 0.044 |
Male | 29 (64.4%) | 7 (46.7%) | 11 (61.1%) | 11 (91.7%) |
|
Onset of symptom to ARDS, median (IQR), days | 8 (3 - 16) | 8 (2 - 19) | 7 (4 - 16) | 7 (2 - 15) | 0.944 |
Contact history of epidemic area |
|
|
|
| |
Wuhan | 30 (66.7%) | 8 (53.3%) | 12 (66.7%) | 10 (83.3%) | 0.238 |
Jingzhou | 15 (33.3%) | 7 (46.7%) | 6 (33.3%) | 2 (16.7%) |
|
Chronic medical illness | 30 (66.7%) | 9 (60.0%) | 15 (83.4%) | 6 (50%) |
|
Diabetes | 4 (8.9%) | 1 (6.7%) | 2 (11.1%) | 1 (8.3%) | >0.99 |
Hypertension | 17 (37.8%) | 6 (40.0%) | 7 (38.9%) | 4 (33.4%) | >0.99 |
Cardiovascular disease | 4 (8.9%) | 1 (6.7%) | 2 (11.1%) | 1 (8.3%) | >0.99 |
Chronic obstructive pulmonary disease | 4 (8.9%) | 1 (6.7%) | 3 (16.7%) | 0 (0%) | 0.434 |
Cancer | 1 (2.2%) | 0 (0%) | 1 (5.6%) | 0 (0%) | >0.99 |
Current smoking | 4 (8.9%) | 1 (6.7%) | 1 (5.6%) | 2 (16.7%) | 0.656 |
Signs and symptoms |
|
|
|
|
|
Fever | 45 (100%) | 15 (100%) | 18 (100%) | 12 (100%) | >0.99 |
Dry Cough | 41 (91.1%) | 14 (93.3%) | 16 (88.9%) | 11 (91.7%) | >0.99 |
Dyspnea | 33 (73.3%) | 8 (53.3%) | 13 (72.2%) | 12 (100%) | 0.017 |
Vomiting | 20 (44.4%) | 6 (40%) | 8 (44.4%) | 6 (50%) | 0.931 |
Fatigue | 22 (48.9%) | 9 (60%) | 8 (44.4%) | 5 (41.7%) | 0.6 |
Chest pain | 40 (88.9%) | 12 (80%) | 16 (88.9%) | 12 (100%) | 0.35 |
Haemoptysis | 1 (2.2%) | 0 (0%) | 0 (0%) | 1 (8.3%) | 0.272 |
Dorsalgia | 6 (13.3%) | 3 (20.0%) | 1 (5.6%) | 2 (16.7%) | 0.477 |
Diarrhea | 8 (17.8%) | 4 (26.7%) | 3 (16.7%) | 1 (8.3%) | 0.486 |